Company announcement

Investor presentation

Financial workbook

Conference call webcast (05 May 2021, 13:00 CET)

Conference call audio link (05 May 2021, 13:00 CET)

London webcast (06 May 2021, 13:00 CET)

London earnings presentation audio link (06 May 2021, 13:00 CET)

Q3 2021 financial results
3 November 2021

Silent period
1 January - 1 February 2022

Q4 2021 financial results release
2 February 2022

28 June: R&D investor call

Presentation (Webcast)

Presentation (pdf)

 

07 June: Approval of Wegovy™ in the US

Presentation (Webcast)

Presentation (pdf)

 

21 May: International Operations call

Presentation (Webcast)

Presentation (pdf)

16 December: Decision to enter phase 3 development in Alzheimer’s disease and GLP-1 R&D strategy update

 

30 November: ESG conference call

9 October: Novo Nordisk raises sales and operating profit outlook for 2020

19 June: R&D investor presentation

Stay informed

Stay informed

Be the first one to read our company announcements and press releases. Sign up to Novo Nordisk News.

Please fill in the fields below to receive our news

E-mail address

Email is required Invalid email address
reCAPTCHA verification required

Investors

Share price

{{priceData.date}} {{priceData.time}}

{{priceData.currentPrice}} {{priceData.currency}}
Go to stock watch {{priceData.change}} {{priceData.currency}}

Annual Report

Annual Report 2020

Download Annual Report